Trevi Therapeutics Inc (NASDAQ:TRVI)
| 2.21 BATS BZX Real-Time Price As of 12:05pm ET |  +0.05 / +2.31%Today’s Change | 1.43 Today|||52-Week Range 3.50 | +14.51% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 4 2017 | Quarter 4 2018 | Quarter 1 2019 | -- | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | -- | -- |
| Depreciation And Amortization | 1.0K | 13.0K | 9.0K | -- | ||
| Operating Expenses | Gross Income | -1.0K | -13.0K | -9.0K | -- | |
| General Expenses | 2.2M | 5.9M | 4.8M | -- | ||
| Research And Development | 1.6M | 4.5M | 3.3M | -- | ||
| Total Operating Expenses | 2.2M | 5.9M | 4.8M | -- | ||
| Non-Operating Expenses | Operating Income | -2.2M | -5.9M | -4.8M | -- | |
| Extraordinary Charge | -10.0K | -148.0K | -52.0K | -- | ||
| Interest Expense On Debt | 195.0K | 0.00 | 0.00 | -- | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -2.4M | -6.0M | -4.8M | -- | |
| Income Taxes | -8.0K | -49.0K | -4.0K | -- | ||
| Preferred Dividend | -1.1M | -1.4M | -1.4M | -- | ||
| Net Income | -2.4M | -6.0M | -4.8M | -- | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 16.1M | 17.8M | 17.8M | -- | |
| Shares To Calculate EPS Diluted | 16.1M | 17.8M | 17.8M | -- | ||
| Earnings Per Share | EPS | -$0.22 | -$0.41 | -$13.85 | -- | |
| EPS Diluted | -$0.22 | -$0.41 | -$0.35 | -- | ||
